RPR-130737

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameRPR-130737
Drug Alias NameRPR-130737
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor X stimulants
TargetsCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRhône-Poulenc Rorer
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRhône-Poulenc Rorer
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A